Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Clinical trial NCT06990867 · RECRUITING

Trial details

NCT number: NCT06990867
Sponsor: Corxel Pharmaceuticals
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2025-05-15
Primary completion: 2029-10-31
Enrollment: 740

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.